NCCM
TRIB

Nine Chapters Capital Management’s Trinity Biotech TRIB Stock Holding History

Nine Chapters Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,140
Closed -$183K – 165
2017
Q1 		$183K Buy
+6,140
New +$192K 0.25% 164
2014
Q3 		– Sell
-4,380
Closed -$504K – 1167
2014
Q2 		$504K Buy
+4,380
New +$519K 0.04% 546

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

Nine Chapters Capital Management's TRIB Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Trinity Biotech (TRIB) in Q2 2017, closing a stake of 6,140 shares — an estimated $183K sold.

Nine Chapters Capital Management first reported a position in TRIB in Q2 2014 and held it in 2 quarters. The position peaked at $504K in Q2 2014. 56 funds tracked by Wall St. Rank hold TRIB as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Trinity Biotech position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 6,140 Trinity Biotech shares in Q2 2017, an estimated $183K.
  • Nine Chapters Capital Management first reported a position in Trinity Biotech in Q2 2014 and held it in 2 quarters.
  • Nine Chapters Capital Management's Trinity Biotech position peaked at $504K in Q2 2014.
  • 56 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.